Cancer Center | Nicklaus Children's Hospital

Neuro-Oncology Program

Treatment of Brain Tumors in Children

The prognosis and survival for children with brain tumors has improved significantly in the last decade. It is now possible to successfully treat a majority of children with such tumors. The Neuro-Oncology Program incorporates a multidisciplinary team who contribute to the diagnosis and treatment of all types of benign or malignant brain tumors.

The Cancer Center works closely with the Nicklaus Children's Hospital Brain Institute to provide the highest quality of care for children with brain tumors. Following appropriate surgical treatment by the world-renowned neurosurgery team, treatment with chemotherapy or radiation therapy may be required.

Types of Brain Tumors in Children

  • Astrocytoma
  • Glioma
  • DIPG
  • Ependymoma
  • Choroid plexus carcinoma
  • Germinoma and germ cell tumors
  • Glioblastoma
  • Spinal cord tumors
  • Atypical teratoid rhabdoid tumors
  • Embryonal brain tumors
  • PNET

The neuro oncology team, led by Dr. Ziad Khatib, provides state-of-the-art treatment for all newly diagnosed and recurrent brain tumors. Novel treatments include chemotherapy for young children to avoid or delay radiation's side effects, stem cell transplantation with high dose chemotherapy and antiangiogenesis therapy to cut the blood supply to growing tumors.

We offer personalized molecular genomic testing of tumors and are involved with novel tumor vaccine trials.

Program Director

Doctor Photo

Ziad A. Khatib, MD

Department of Hematology/Oncology

Contact the Cancer Center

Lacy's Success Story
At only 2 years old, Lacy needed to have a tumor removed from her brain; she also went through six months of chemotherapy and a stem cell transplant. Today, Lacy is cancer free and going to different therapies to continue getting stronger every day.

Designated as a Blue Distinction Center for Transplants


Recognized by the American College of Surgeons Commission on Cancer


Accredited by the Foundation for the Accrediation of Cellular Therapies (FACT)